Jane Street’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.3M Buy
917,900
+65,800
+8% +$1.93M ﹤0.01% 1616
2025
Q4
$24.7M Buy
852,100
+423,900
+99% +$12.7M ﹤0.01% 1442
2025
Q3
$11.9M Buy
428,200
+88,700
+26% +$2.24M ﹤0.01% 2196
2025
Q2
$8.27M Buy
339,500
+277,300
+446% +$6.08M ﹤0.01% 2374
2025
Q1
$1.29M Buy
62,200
+47,100
+312% +$1.18M ﹤0.01% 5095
2024
Q4
$356K Sell
15,100
-68,800
-82% -$1.69M ﹤0.01% 7445
2024
Q3
$2.15M Buy
83,900
+22,000
+36% +$560K ﹤0.01% 4333
2024
Q2
$1.45M Sell
61,900
-38,000
-38% -$959K ﹤0.01% 5067
2024
Q1
$2.87M Sell
99,900
-211,000
-68% -$6.35M ﹤0.01% 3476
2023
Q4
$10.2M Buy
310,900
+188,800
+155% +$5.13M ﹤0.01% 1928
2023
Q3
$3.4M Sell
122,100
-800
-0.7% -$26.2K ﹤0.01% 3179
2023
Q2
$4.19M Buy
122,900
+28,600
+30% +$899K ﹤0.01% 2987
2023
Q1
$2.84M Sell
94,300
-381,800
-80% -$11.8M ﹤0.01% 3239
2022
Q4
$13.4M Sell
476,100
-390,000
-45% -$12.4M 0.01% 1331
2022
Q3
$28.5M Buy
866,100
+270,200
+45% +$9.92M 0.01% 819
2022
Q2
$18.8M Sell
595,900
-90,400
-13% -$3.16M 0.01% 1167
2022
Q1
$31.5M Buy
686,300
+339,600
+98% +$16.2M 0.01% 945
2021
Q4
$21.2M Sell
346,700
-153,400
-31% -$10.6M 0.01% 1166
2021
Q3
$37.4M Sell
500,100
-215,900
-30% -$18.1M 0.01% 735
2021
Q2
$66.2M Sell
716,000
-339,100
-32% -$28.8M 0.03% 435
2021
Q1
$93.6M Buy
1,055,100
+1,015,300
+2,551% +$101M 0.05% 292
2020
Q4
$3.71M Buy
+39,800
New +$3.17M ﹤0.01% 2513

Other funds holding ARKG

Jane Street's ARKG Position: Q1 2026 in Review

Jane Street reduced its ARK Genomic Revolution ETF (ARKG) stake by 83% in Q1 2026, selling an estimated $14.2M and leaving 96,335 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4647.

Jane Street first reported a position in ARKG in Q4 2014 and has held it in 41 quarters since. The position peaked at $71.8M in Q4 2020. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Jane Street held 96,335 shares of ARK Genomic Revolution ETF worth $2.55M as of Q1 2026.
  • Jane Street sold 484,079 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $14.2M.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4647 holding.
  • Jane Street first reported a position in ARK Genomic Revolution ETF in Q4 2014 and has held it in 41 quarters since.
  • Jane Street's ARK Genomic Revolution ETF position peaked at $71.8M in Q4 2020.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.